CAPLIPOINTCaplin Point Laboratories Ltd.

    Caplin Point Laboratories Ltd: results and news

    Every Caplin Point Laboratories Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Pharmaceuticals · Latest 12 Nov 2026

    A pile of white, orange and green-and-white capsules and tablets with a glass thermometer lying across them.

    CAPLIPOINTCaplin Point Laboratories Ltd.

    Caplin Point Laboratories Q2 FY27 Results: Consolidated Net Profit ₹182 Crore on Total Income of ₹663 Crore

    Caplin Point Laboratories (NSE: CAPLIPOINT) reported consolidated total income of ₹663.13 crore and net profit of ₹182.35 crore for the quarter ended 30 Sep 2026, it said in a filing on 12 Nov 2026. Standalone total income was ₹292.92 crore and standalone net profit ₹130.51 crore.

    • Earnings
    • Pharmaceuticals

    Blacklitt Research2 min read